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Controlled comparison of hemodialysis and peritoneal dialysis: Veter-
ans Administration multicenter study. We measured mortality and
morbidity among 114 patients assigned randomly to home hemodialysis(HD) and home intermittent peritoneal dialysis (IPD). Data were
collected during the time of home training and for 12 months after
initiation of home dialysis. Training time was shorter for the IPD than
for the HD patients (P < 0.001) with median time 1.8 months for IPD
and 3.9 months for HD. Switching to the alternative mode of treatment
was more frequent for the IPD group (29/59 vs. 5/55, P < 0.001).
Survival time was not different, perhaps because of the modality
change. More IPD patients were hospitalized in the first 6 months (20
for IPD vs. 9 for HD, P = 0.02), but they had fewer troublesome
cardiovascular events in the first year (0 vs. 12, P < 0.001). The HD
patients maintained better nutritional status as reflected in body weight
and arm muscle circumference and possibly in urea appearance rate.
Thus, these data suggest that for most patients, IPD is a less satisfac-
tory form of therapy than HD, but certain advantages of IPD did
emerge. Applications of this information to the currently more popular
mode of CAPD await further study.
Comparaison contrôlée entre l'hemodialyse Ct Ia dialyse péritonéale:
Etude multicentrique de l'Administration des Veterans. Nous avons
mesuré la mortalité et Ia morbiditë chez 114 malades, pris au hasard, en
hmodialyse a domicile (HD) ou en dialyse péritonéale intermittente a
domicile (IPD). Les données ont ét recueillies pendant l'entrainement
domicile et pendant les 12 mois suivant Ic debut de la dialyse a
domicile. La durée d'entrainement était plus breve pour les malades en
IPD que pour ceux en HD (P < 0,001), avec un temps median de 1,8
mois pour l'IPD et de 3,9 mois pour l'HD. Le changement pour l'autre
mode de traitement ëtait plus frequent pour Ic groupe IPD (29/59 contre
5/55, P < 0,001). La durCe de suivi n'était pas différente, peut-Ctre a
cause du changement de modalitC. Plus de malades en IPD ont été
hospitalisés dans les 6 premiers mois (20 en !PD, contre 9 en HD, P =
0,02), mais us ont eu mains d'ennuis cardiovasculaires génants au cours
de Ia premiere annCe (0 contre 12, P < 0,001). Les malades HD
conservaient un meilleur état nutritionnel, reflété par Ic poids corporel,
Ia circonférence musculaire du bras, et probablement Ia vitesse
d'apparition de l'urée. Ainsi ces donnCes suggérent que pour Ia plupart
des malades, l'IPD est une forme de traitement mains satisfaisante que
l'HD, mais certains avantages de I'IPD sont apparus. Les applications
de cette information au mode actuellement Ic plus répandu de CAPD
requièrent d'autres etudes.
select the therapy that may best enhance a patient's outcome
potential, whether the potential is real or assumed [1—3]. Recent
studies have attempted to circumvent the analytic problems
arising from this practice by collating patient characteristics so
that later comparisons can be made from demographically
similar groups [4, 5]. Those attempts, however, may be only
partially successful because the unstated bias in patient assign-
ment likely remains.
To obtain an evaluation based on classic randomization
techniques, thus controlling for the extraneous variables of
biased selection of subjects, we conducted a nationwide ran-
domized cooperative study in which patients with endstage
renal failure were randomly assigned to one of the two major
modes of dialysis therapy, hemodialysis (HD), or peritoneal
dialysis (PD). Initiated in 1975 and spanning 5 years of data
collection at five centers, the study was carried out under the
auspices of the Veterans Administration Cooperative Studies
Program [6]. This paper presents the results.
Rationale of the study design. The study was designed
primarily around the need to control for the selection of
patients. However, other considerations guided the design of
the study. Home dialysis was chosen as the basis of both modes
of therapy because of the impracticality of administering PD in
a hospital facility.1 Moreover, the investigators were propo-
nents of prescribing home dialysis wherever possible. Another
design consideration dealt with the problem of treatment dose.
A few patients designated home HD actually cared for themselves
in the facility as if they were at home, a process often called 'self-
dialysis." They are included in the home HD group for the purpose of
this report.
In studies to date that compare the outcome of treatment
among two or more modes of maintenance dialysis therapy, the
evaluations are confounded by the nonrandom assignment of
patients to treatment groups. Physicians admittedly tend to
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Rather than arbitrarily select treatment schedules in an attempt
to normalize theoretical or calculated solute removal rates, we
chose to use the standard treatment protocols of the day. For
HD, it was single-pass hemodialysis for 10 to 14 hr a week in
three treatment sessions. For PD, it was intermittent peritoneal
dialysis (IPD) for approximately 35 hr a week in three to four
sessions. A final design consideration dealt with physician-
investigator discretion in changing treatment modality. We
chose to allow complete discretion and to record these deci-
sions as events.
For evaluating outcome, we used a wider selection of out-
come measures than the ones usually used. Most other studies,
new and old, rely on easily available parametric data, such as
the serum concentrations of urea, creatinine, sodium, potas-
sium, bicarbonate, and serum protein values [7—9]. Although
similar data were obtained and compared in this study, we also
included certain other factors that probably have a stronger
influence on both the physicians' and the patients' assessments
of outcome: the number of morbid events, their impact on the
assessment of well-being, the frequency and duration of hospi-
talizations (including a semiquantitative assessment of the
outcome of events), and the emotional and nutritional status of
patients.
In spite of all caution, however, the design of the study
suffered two problems. The first was the difficulty of comparing,
quantitatively, the dialysis dosages of the two very different
treatment techniques. In the absence of knowledge about the
specific toxins (or toxin) whose concentrations are presumably
being lowered by dialysis, and in the absence of uniform
opinions on the adequacy of the dialysis prescription itself, we
elected to compare the two therapies in terms of how they were
actually being practiced in the community and in the participat-
ing hospitals. Even though a common base comparison is
difficult, we have provided some comparative data.
The second problem was the choice of IPD as the rep-
resentative mode of peritoneal dialysis. Several years after the
study was designed, the newer technique of continuous ambula-
tory peritoneal dialysis (CAPD) began to gain such worldwide
popularity that IPD quickly became considered an outdated
form of therapy [101. In spite of this unforeseeable develop-
ment, however, there was still merit for continuation of the
study and for the results to be made available to others. The
principal difference between IPD and CAPD is that CAPD
provides fluid in the abdomen continuously except during the
time of the exchanges. CAPD also has a slower exchange rate
(approximately 0.3 to 1.0 liters/hr) than IPD does (4 liters/br).
Because of its relative ease of use, some theoretical advantages
[111, and a general consensus that IPD does not provide a
satisfactory maintenance therapy, CAPD has become the pre-
ferred choice [12—141. But the current disfavor for IPD is not
based on carefully collected evidence. In fact, the medical
literature before the ascendance of CAPD suggests that IPD is
a very useful form of therapy when carried out with the same
enthusiasm usually reserved for hemodialysis [15—18]. Ironi-
cally, despite the initial optimism for CAPD, now it, too, is
coming under skeptical scrutiny, largely because of reported
high patient dropout rate [5, 19].
Thus there were two reasons for continuing the study. The
first was that it would represent the only randomized-controlled
evaluation for the two predominant modes of dialysis. The
second reason for continuation was to allow a more thorough
understanding of the analytical advantages and disadvantages
of a randomization-based study protocol in the assessment of
dialysis treatment.
Methods
The study protocol was approved by the Human Studies
Committee at each participating institution and by a central
Human Rights Committee at the Veterans Administration (VA)
Cooperative Studies Program Coordinating Center at the West
Haven VA Medical Center before it was initiated. The study
was monitored by an independent Operations Committee2 and
by the Human Rights Committee during the course of the study.
Patient selection. From November, 1975 through November,
1979, at each of the five participating hospitals, all nondiabetic
veterans with endstage renal disease who presented for care
were screened for possible randomization. Of the 398 patients
screened, eight could not be considered further owing to their
early death or to plans for transferring them immediately to
another institution. Admission criteria [61 excluded 209
others, who were either ineligible because they would admit
other concomittant conditions or were rejected for practical
considerations.
Exclusions based on ineligibility were as follows (number of
patients in parentheses): female (3); over age 65 (28); the
presence of substantial residual renal function, that is, a serum
creatinine concentration of less than 8 mg/dl and a creatinine
clearance of greater than 8 mI/mm (13); maintenance dialysis in
progress more than 4 months (6), previous bilateral nephrec-
tomy (12), the presence of lupus erythematosis (4); the presence
of active malignancy (17), or other major medical problems (20).
Although amyloidosis and prior renal transplantation were
criteria for ineligibility, no patient fell into these categories.
The reasons for rejection were: an early transplantation was
planned (22), full care was needed by the patient (20), a
referring physician had made specific recommendations (13), or
the physician-investigator felt that IPD was unacceptable (32)
or that HD was unacceptable (84). These reasons for rejection
were not mutually exclusive.
The remaining 181 eligible and suitable (that is, not rejected)
patients were asked to participate in the study and to be
assigned randomly to one of the two forms of home dialysis.
This process of informed consent has been described in detail
elsewhere [20]. In brief, the advantages and disadvantages of
each type of dialysis were explained; the patients were shown a
video tape describing the two forms of therapy and were
allowed to review the tape as often as they wished; and a
questionnaire was completed after this instruction. The study
design allowed randomization to be done before initiating
dialysis therapy or within 4 months after its initiation. As a
result of these explanations, 67 of the 181 patients chose to
2 The Operations Committee was comprised of experts in the subject
matter of the study, a biostatistician, and other appropriate technical or
scientific specialists. The members must not have been participants or
consultants in the planning or execution phases of the study. It provided
a continuing critical and unbiased evaluation of the study's progress and
formulated operational policy consistent with the best current biomedi-
cal research practice. Members of the Committee are listed in the
Appendix.
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Table 1. Patient accession at each institutiona
Not
Institution
Screened
N
considered
N
Ineligible
N
Rejected
N
Refused
N
Randomized
N
A 93 1(1) 9 (10) 32 (34) 24 (26) 27 (29)
B 64 0(0) 11(17) 31(48) 6 (9) 16(25)
C 114 2 (2) 30 (26) 30 (26) 16 (14) 36 (32)
D 90 5(6) 35(39) 22(24) 11(12) 17(19)
E 37 0(0) 4(11) 5(14) 10(27) 18(49)
Total 398 8 (2) 89 (22) 120 (30) 67(17) 1/4 (29)
a Numbers in parentheses are the percent of those screened; N is the number of patients in each group.
select one of the therapies rather than enter randomization: of
these, 44 selected home HD and 23 selected home PD.
The remaining 114 patients were assigned to one of the two
alternative forms of therapy; assignment was based on a table of
random numbers. These 114 patients are the subject of this
report. Table 1 summarizes their progression through the ac-
cession procedure. Treatments were randomized within each
institution and each age stratum: age under 50, and age 50 and
over; there were 45 patients under age 50 and 69 who were age
50 and over. Fifty-five patients were assigned randomly to HD
and 59 to PD.
Table 2 compares the randomized patients with the non-
randomized patients (those who refused study participation,
those who were ineligible, and those who were rejected) with
respect to demographic, clinical, and psychologic status. In
evaluating clinical status, we considered the specific features of
the patients' condition, including the cause of renal failure,
average blood pressure, and residual creatinine clearance be-
fore dialysis therapy was required (if the data were available).
We also assessed the presence of significant co-morbidity in
other organ systems (skin, cardiac, pulmonary, gastrointestinal,
hepatic, endocrine, musculoskeletal. central nervous system,
psychiatric, and hematologic) by a standard scoring system,
which is described under the section on Clinical and laboratory
assessment. Psychologic status was assessed by the Structured
and Scaled Interview to Assess Maladjustment (SSIAM), which
is an indicator of the real-life adjustment of the patient in family,
social-leisure, marriage, sexual, and working status [21, 22],
and by the Multiple Affect Adjective Check List (MAACL),
which provides a rapid measure of the mood of the patient [221.
Clinical and laboratory assessment. Survival time from first
dialysis was compared in the two treatment groups. A death
occurring within 3 months after switching to an alternative form
of dialysis was considered a death within the assigned group;
however, a death following any transplantation which took
place after beginning dialysis treatments was not considered a
dialysis-related mortality.
Assessments of outcome including morbidity were carried
out at the following intervals: (1) at the time of the first regularly
scheduled dialysis treatment; (2) at the time home-dialysis
began; and (3) approximately 6 and 12 months later. The precise
timing of the 6th and 12th month assessments varied owing to
practical considerations, including patient convenience. The
average deviation from the precise date of the 6-month follow-
up was —3 42 days (SD) for the HD patients and —18 35
days for the IPD patients. The deviations were not significantly
different at the 5% level. Similar results were noted at the 12
month follow-up.
Data on clinical, laboratory and psychological status 3
months after a patient was permanently re-assigned to the
alternative treatment mode were also included in the assess-
ment of the randomly assigned dialysis mode.
Morbidity was assessed at the 6 and 12 month intervals using
clinical, laboratory, and psychological parameters. For several
clinical assessments, we used a 6-tiered, ordinal scale, referred
to here as the standard scale: Score 1: Normal or absent; Score
2: Borderline normal or possibly present; Score 3: Definitely
abnormal but of little or no functional significance; Score 4:
Functionally significant but of slight importance; Score 5:
Important but not life-determining; Score 6: Functionally life-
determining.
Morbidity was also assessed by the frequency and duration of
hospitalizations. As a part of this assessment, we maintained an
inventory of the impact of hospitalization by the use of a
six-tiered semiquantitative assessment similar to the standard
scale and ranging from better off (score 1) to very seriously ill
(score 6). Additional information was collected for the nature
and severity of episodes of dialysis-access failure, myocardial
infarction, cerebral vascular accident, peritonitis, and hepatitis.
Records were maintained for the number of blood transfusions,
the presence of mild or severe motor and sensory neuropathy
(assessed according to vibratory sense), and the patients'
general cardiac status (assessed according to criteria set by the
New York State Heart Association). Dialysis-related symp-
tomatology was assessed, and scored by the same standard
scale, for symptomatic hypotension, muscle cramps, nausea,
and post-dialysis lethargy.
Blood and serum parameters were assessed every 3 months
by standard clinical laboratory methods. These parameters
were hematocrit, serum creatinine, urea nitrogen, uric acid,
calcium, phosphorus, alkaline phosphatase, and albumin. A
psychologic assessment was carried out at 6- and 12-month
intervals by the SSIAM. Nutritional status was assessed by
anthropometric studies (estimated dry weight and measured
upper arm muscle circumference) [25] and urea generation rate
measurements (dialysate loss plus any renal loss) [26]. Arm
muscle circumference was calculated by subtracting the tricep
skinfold thickness from the mid upper arm circumference.
Also assessed was the time required to achieve home dialysis
and the duration of treatment adherence. Those patients ran-
domly assigned to one form of therapy but then, by physician or
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Table 2. Characteristics of participants and non-participants in randomized trial of dialysis modality
Randomized Non-randomized P
Number of patients 114 276
Age, yr (114) (272)
SEM 50.3 0.9 51.7 0.7 0.25
Race, % (114) (272)
White 54.4 51.1
Black 41.2 48.5
Other 4.4 0.4 0.56
Education, % (114) (256)
<7 years 13.2 14.8
7 but <12 years 42.1 35.9
High school graduate 21.9 31.3
Partial college 11.4 11.7
College graduate 11.4 6.3 0.20
Occupation, % (113) (261)
Officers & managers 23.0 24.5
Skilled & career enlisted 54.9 50.2
Semi-skilled 22.1 25.3 0.69
Hometown population, % (114) (266)
<10,000 43.9 33.5
10,000to99,999 31.6 36.5
l00,000 24.6 30.1 0.15
No others in home, % (114) (261)
0 4.4 11.9
1 27.2 39.5
68.4 48.7 0.001
Cause of failure, % (114) (276)
Glomerulonephritis 35.1 27.5
Polycystic kidney disease 10.5 5.4
Pyelonephritis 0.9 4.3
Nephrosclerosis 21.9 25.0
Interstitial nephritis 8.8 8.0
Nephrolithiasis 0.9 1.8
Other renal disease 3.5 12.7
Unknown 18.4 15.2 0.03
Creatinine clearance (88) (183)
Mean SEM 4.3 0.4 5.0 0.3 0.09
Systolic pressure, mm Hg (109) (267)
Mean SEM 144 2 144 1 0.83
Diastolic pressure, mm Hg (109) (267)
Mean SEM 85 1 84 1 0.82
Co-morbidity severity (114) (276)
% with 2 organ systems, each with score >3 48 55 0.20
% with Cardiac or Pulmonary score >3 47 54 0.23
% with Psych. or Neuro. score >3 15 25 0.03
Multiple Affect Adjective Check List" (110) (223)
Anxiety 4.88 0.39 5.69 0.30 0.11
Depression 10.62 0.66 11.29 0.48 0.42
Hostility 4.20 0.34 4.23 0.25 0.95
Maladjustment Interview (110) (218)
Overall scorec 2.72 0.08 2.86 0.06 0.15
Symbol: ( ), indicates number of patients reported.
a Scoring is described in Methods.
b Scoring is described in [21, 221.
Scoring is described in [23].
Fig. 1. Survival curves for patients assigned
random/v to hemodia/ysis and peritoneal dial-
ysis. Data 3 months after the change of dialysis
therapy are excluded from analysis (censored).
No significant difference in survival time was
observed.
patient judgement, reassigned permanently to the other form of
therapy were classified as withdrawals from the study.
Statistical methods. Three types of statistical analysis were
used: (I) Hypothesis of equal proportions or identical distribu-
tions for categorical data were tested by the chi-square test
statistic with appropriate degrees of freedom [27]. Fisher's
exact test was used whenever the expected value in a cell of 2
x 2 table was five or less; (2) hypothesis of equal means for
continuous variables were tested with the t-statistic [27]; (3)
curves for HD and IPD were constructed by the product-limit
method of Kaplan-Meier [281 for each of the following vari-
ables: Survival time from first dialysis, duration from first
dialysis to completion of home-care training, and duration of
adherence to assigned therapy after achieving home-care. The
generalized Wilcoxon test [29] was used for comparison of the
curves between HD and IPD. The approach proposed by Cox
[24] was also adopted to test the treatment effect after adjusting
for age.
The probability under the sampling distribution that the test
statistic was equal to or more extreme than the observed value
was calculated for each of these tests. The level of significance
was set at 5%.
Results
Characteristics of randomized and non—rando,nized patients.
As noted earlier, we excluded certain groups of patients from
the randomization process. In view of the possible application
of these results to other patients we compared selected charac-
teristics (Table 2) between the aggregate non-randomized group
(consisting of the rejected, ineligible and ref used subgroups)
and the randomized group. The two groups were similar in the
following categories: age, race, education, occupational expe-
rience, size of hometown, and residual renal function. The
randomized group differed from the non-randomized aggregate
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Time, months from onset of dialysis
Table 3. Causes of treatment change for randomized patients
Transfer from
PHD to IPD IPD to HD
Before home-care
After homecarea
2/55 (3.6%)
3/42 (7.1%)
5/59 (8.5%)
24/47 (51.5%)
0.28
<0.001
Total 5/55 (9.1%) 29/59 (49.2%) <0.001
Principal reason
Medical
Technical
Patient and/or family
Staff-initiated
None given
3b
1
1
0
0
l4C
5
3
3
4
a There were reasons for discontinuing assigned therapy before
achieving home-care other than transfer to alternate therapy. Of 55
assigned to HD home-care, two received a renal transplant, four died,
three were unwilling or unable to complete training and two were alive
but not yet finished training at the end of the study. Of 59 assigned to
peritoneal dialysis, four died, one was unwilling to complete training
and two were on dialysis for a short duration and then required no
dialysis for the next 3 years.
b One reported two principal reasons, including medical.
Four reported two principal reasons, including medical.
group in that they had slightly larger families at home, higher
frequency of glomerulonephritis, and less neuropsychiatric
co-morbidity. Other characteristics not listed in 'I'able 2 were
also compared. No difference was noted for the presence or
severity of dyspnea, angina, cardiac enlargement, or motor
strength. As expected the patients randomized to HD and IPD
were similar with respect to all the characteristics considered.
Dialysis dosage. The patients assigned to home HD were
treated 11.5 1.6 (SD) hr a week. The HD patients used blood
1.0
0.9
0.8
0.]
. 0.6
>
j 0.5
000
a.
0.3
0.2
0.1
0.0
o Hemodialysis
• Peritoneal
0 6 12 18 24 30 36 42 48 54 60 66
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flows of 180 to 250 ml/hr, with dialysate rates of 500 mI/mm.
Dialyzers with nominal urea clearance of 97 to 175 mI/mm at
blood flow rates o1 200 mI/mm were used. The calculated
dialysis urea clearance were between 59 and 133 liters/week
(average: 104 19 liters/wk).
All patients assigned to home IPD used automated equipment
that exchanged peritoneal fluid at a rate of 4 liters/hr. Treatment
Fig. 2. Actuarial curves for time required to
complete home training. The median training
time was approximately 2 months shorter for
peritoneal dialysis patients and the difference
was significant.
Fig. 3. Actuaria/ curves for duration of adher—
cove to assigned therapy. Patients randomly
assigned to peritoneal dialysis dropped out of
this dialysis therapy approximately It) months
earlier than those assigned to hemodialysis and
66 the difference was significant.
duration was 34.9 7.2 (so) hr/wk, usually in three to four
sessions a week. Assuming that average urea clearance was 25
mI/mm. the average weekly urea clearance was approximately
52 ii liters/week.
Study results. Of the 114 patients randomly assigned to either
home HD (55) or home IPD (59). all but one actually entered
their assigned therapy he died before starting therapy. Of those
o Hemodialysis
• Peritoneal
0
Time, months from onset of home care
16 18 20
o Hemodialysis
• Peritoneal
Time, months from onset of home care
54 60
At risk (beginning of period)
Hospitalization
No. admissions'
No. of patients admitted > 1 time
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Average duration SEM for those hospitalized, days
Dialysis access malfunction requiring surgical revision
No. events (no. patients)
No. with moderate morbidity or greater
No. deaths
Not requiring surgical revision
No. deaths
Cardiac incidents
Arrhythmia
Angina (new or worse)
Myocardial infarction
Cardiac decompensation
Pericarditis
Total no. incidents'
No. with moderate morbidity or greater
Peritonitis
No. eventsa
No. patients
No. with moderate morbidity or greater
a Student's t test was used.
p < 0.05.
P < 0.01.
P <0.00!.
2 (2)
0
0
2
who entered therapy, 89 (42 HD patients, 47 IPD patients)
successfully completed training for dialysis at home or for
dialysis in the facility done entirely by themselves self care).
Older patients (50 years) achieved home-care as frequently
(36/45 — 80%) as younger patients did (53/69 — 77%).
Survival curves from first dialysis (Fig. I) were not signifi-
cantly different between HD and IPD (P = 0.40). The median
survival time was greater than 61 months for HD, and greater
than 50 months for IPD. The treatment effect was not significant
after adjusting for age (P — 0.53) by the Cox method [24]. The
survival curves were also not significant between the two
groups after achievement of home-care stalus (P 0.96). The
median survival time was greater than 59 months for HD and
greater than 49 months for IPD. The treatment effect after
adjusting for age was also not significant (P = 0.99).
The time from initiation of dialysis treatment to achievement
of home-care dialysis status was significantly shorter for the
IPD group (P <0.001) with median duration 3.9 months for HD
and 1.8 months for IPD (Fig. 2). But the duration of adherence
to the assigned therapy after achieving home-care status was
considerably greater or longer for the HD group (P < 0.01) with
median duration for HD greater than 60 months, while the
median duration for IPD was 25.4 months (Fig. 3). The treat-
ment effect was also significant after adjusting for age (P <
0.001). Overall, 29 of the 59 patients randomized originally to
IPD were transferred to HD, and five of them did so before
achieving home-care status (Table 3). In contrast, only five of
those randomized to HD transferred to IPD (P < 0.001). The
reasons for transfer were given as "medical" in most cases,
regardless of which change was made. Temporary assignment
to the alternate form of dialysis was required during hospitaliza-
tion of five IPD patients for between 25 and 47 days; and for two
HD patients for 22 and 36 days.
Results of the detailed statistical analysis of morbidity of the
randomized patients after they achieved home-care status are
presented in Tables 4 and 5. In the first 6 months, there were 30
hospitalizations of 20 IPD patients, a sharp contrast with the
only nine hospitalizations, each for a separate patient, during
that time for the HD patients (P < 0.001). In the second
6-month period, with fewer IPD patients at risk, the frequency
distribution of hospitalizations was similar. The duration of
hospitalization for those hospitalized was not statistically dif-
ferent in either 6-month period.
Dialysis-access malfunction for both forms of dialysis was
compared for frequency and severity. Two HD patients died as
a result of dialysis-access malfunction (one of endocarditis and
the other, of pulmonary edema after dialysis was delayed) but
the proportion of difficulties requiring surgical revision seemed,
if anything, less in this group (9.5% for HD and 12.8% for IPD),
though the difference was not significant statistically. In over
Table 4. Major morbidity after achieving home care
First 6 months
HD 1PD HD
Second 6 months
IPD
42 47 38 38
9 305 20 28
0 7 6 8
16.3 3.2 18.3 -- 2.8 24.0 5.8 28.4 5.8
7 (4)
3
9 (6)
5
7 (5)
3
0 0
3 2 3
0 0 0
1 0 2 0
0 0 1 0
0 0 0 0
2 0 3 0
1 0 2 0
4 8
1 0 1 0
1 2l 0 17C
I 13C 0 10d
0 9C 0 8C
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Table 5. Other outcome features for randomized patients after achieving home carea
First 6 months Second 6 months
HD IPD HD IPD
No. of patients at onset 42 47 38 38
Clinical parameters
No. of patients 41 45 36 36
Pts. receiving transfusions 6 7 6 8
Avg. units blood rec'd 3.7 0.8 5.6 1.9 7.3 3.4 5.9 3.0
Systolic BP, mm Hg 148 2 152 3 154 4 147 3
Diastolic BP, mm Hg 83 2 87 2 86 2 85 2
Use of anti-hypertensive agents (No. of patients) 10 23C 12 20
Avg. weight gain, kg between treatments 3.7 0.3 6.0 0.4e 4.5 0.5 5.3 0.5
Swelling of ankles (No. of patients) 5 15 5 11
Dialysis symptoms
Muscle cramps 26 (63%) 18 (40%)C 26 (72%) 16 (44%)c
Moderate or worse 6 (15%) 6 (13%) 8 (22%) 4 (11%)
Nausea 19 (46%) 4 (9%)e 17 (47%) 2 (6%)C
Moderate or worse 6 (15%) 2 (4%) 8 (22%) 2 (6%)c
Hypotension 16 (39%) 11(24%) 12 (33%) 8 (22%)
Moderate or worse 5 (12%) 3 (7%) 4(11%) 2 (6%)
Nutritional parameters
Pre-dialysis weight, kg 71 2 70 2 71 2 71 2
(37) (40) (32) (29)
Change in body weight' +0.4 0.7 —0.8 1.1 —0.0 0.8 —3.5 1.1
(35) (33) (30) (26)
Arm circum. corrected, cm 28.4 0.6 28.3 0.5 28.4 0.6 28.3 0.6
(37) (40) (32) (29)
Change in arm circum.5 0.7 0.3 —0.3 0.4c 0.1 0.4 —1.0 0.4c
(35) (33) (30) (26)
Urea appearance rate 8.5 0.6 6.8 Ø4c 8.4 0.4 7.3 0.5
(36) (37) (31) (34)
Laboratory parameters
Number of patients 41 44 36 37
Hematocrit, % 24.1 0.7 25.2 0.9 24.6 0.9 24.2 0.8
(43)
Serum urea nitrogen, mg/dl 78 3 75 3 81 3 81 3
Serum creatinine, mg/dl 14.9 0.7 16.5 0.8 15.5 0.7 17.7 0.8c
Serum uric acid, mg/dI 8.4 0.3 9.2 0.3e 8.3 0.3 8.8 0.2
(40)
Serum albumin, gIdi 4.0 0.1 3.5 Ole 4.0 0.1 3.5 0.1
Serum calcium, mg/dl 9.5 0.1 8.8 0.2e 9.5 0.2 8.8 02d
Serum phosphorus, mg/dl 5.0 0.2 5.5 0.3 5.3 0.3 6.0 0.3
Psychosocial parameters
Multiple affect adjective checklist
Number of patients 35 34 27 25
Anxiety 3.89 0.63 3.62 0.57 4.63 0.84 3.32 0.72
Depression 8.80 0.92 7.15 0.86 10.44 1.53 8.32 1.12
Hostility 3.09 0.39 3.09 0.47 4.11 0.84 4.00 1.06
Maladjustment interview
Number of patients 36 35 28 26
Overall 2.53 0.14 2.37 0.15 2.68 0.17 2.42 0.15
a All values are mean SEM.
b Changes were calculated between the first and the last values in each period. The last observation within each period was used for the other
parameters.
P < 0.05.
P <0.01.
P < 0.001.
one-half of the recorded instances of peritoneal-access mal- significant disproportionate number of events in the second
function, the problem was associated with "moderate or 6-month period among patients assigned to HD. Three of the 12
worse" morbidity. A malfunction that did not require surgical cardiac incidents were a source of moderate morbidity during
revision was relatively less frequent and of similar distribution the first year in the HD group.
in the two groups. Peritonitis. as expected, was virtually confined to IPD pa-
An inventory of cardiac incidents revealed a statistically tients and was associated with 20 of 58 hospitalizations (>5
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days) during the first year for this group. In addition, there were
13 incidents of peritonitis which led to shorter hospitalizations
and five episodes treated as outpatients. In 31 of the 38
episodes, the associated morbidity was moderately severe or
worse.
Only one patient (HD group) had a cerebral vascular event
during the first year after achieving home-care status. No
patient from either group developed hepatitis.
Other outcome features are shown in Table 5 and are divided
into clinical, nutritional, laboratory, and psychological cat-
egories. Only selected clinical observations are shown in the
tables and will be reviewed here along with many which are not
shown. There was no difference in the number of blood trans-
fusions in the two groups of patients. Average systolic and
diastolic blood pressure values were similar, but fewer HD
patients were treated with antihypertensives. a difference which
was significant statistically in the first 6 months. Interdialytic
weight gains (presumably fluid weight) were higher in the IPD
group, and again this difference was significant in the first 6
months. Related to this, was the observation of peripheral
edema in more IPD than HD patients in the first 6-months (P =
0.03). but there was no difference in the second 6 months (P =
0.10). The use of digitalis or antiarrhythmic drugs, the fre-
quency of abnormal electrocardiogram, and the frequency or
severity of dyspnea, angina, or arrhythmia were not different in
the two groups. Nor was there a difference in the frequency of
weakness or sensory abnormalities between the two groups.
Dialysis-related symptoms tended to be more common
among the HD patients and the difference for "muscle cramps"
was significant during the second 6-month period. Nausea, in
particular, was a feature of HD patients' dialysis symptomatology.
We also assessed selected parameters intended to reflect
changes in the patients' nutritional status. Whereas the average
pre-dialysis body weight (selected as a useful surrogate measure
of div n'eight changes because patients were more likely to
record these weights) was similar in both groups, the IPD
patients who completed the surveillance period lost dry weight,
a statistically significant (P = 0.01) difference in the second
6-month period. The absence of a statistical difference between
the average weight of the IPD patients at the beginning and end
of the second period is explained by the fact that patients
dropping out of IPD before the end of the period were lighter at
the beginning than those remaining (63.7 2.8 vs. 74.4 2.6
kg. P < 0.05). Trends and statistical comparisons of the
corrected arm circumference were similar. Protein intake as
reflected by urea appearance rate [261 appeared to be lower
among the IPD patients during the first 6 months and probably
lower during the second 6 months, though it did not reach
statistical significance.
Except for a slightly but significantly lower serum concentra-
tion of albumin and calcium in the IPD group, laboratory
parameters were essentially the same in both groups throughout
the study. Of special note was the absence of a difference in
hematocrit values between the two groups. Psychological status
appeared to be similar in both groups and unchanged from one
assessment period to the other.
Discussion
In interpreting the results of the study, one must keep in mind
the study design and its possible impact on the study outcome.
In particular, these results cannot be extrapolated to expected
outcome of current CAPD patients in comparison to
hemodialysis patients. The present data suggest that survival
times are the same for patients assigned to home hemodialysis
and home intermittent peritoneal dialysis where modality re-
assignment was available. Re-assignment was permitted when
the attending physician and patient concluded that the patient's
clinical status was unsatisfactory and might improve with
modality change. The interpretation of morbidity data is more
complex. Hospitalization was excessive among the TPD pa-
tients, largely due to peritonitis. Control of fluid accumulation
and hypertension was more difficult among the IPD patients. On
the other hand, dialysis symptomatology, especially nausea,
was greater among the HD patients. Moreover, the HD group
seemed to have more frequent and more severe cardiovascular
morbidity including two deaths associated with vascular access
problems. The most apparent overall differences in outcome
between the two modes of therapy were that (1) the period of
training needed to achieve home-care was relatively shorter
with IPD, (2) the dropout rate and change of therapy was
greater among the IPD patients, and (3) the nutritional status
was relatively poorer for the IPD group, as reflected in the
decreased body mass.
The shorter training time for IPD is due to the reduced
complexity of the procedure and the relative lack of anxiety
about it. This is in contrast with the anxiety and critical need for
mastery of safety precautions when extra-corporeal blood cir-
culation is required.
The higher dropout among IPD patients is explained less
easily. Since the participating physicians were experienced and
comfortable with home IPD, dropout probably does represent a
genuine concern for the patients' condition and not a program
bias. No doubt, the frequent episodes of peritonitis and the
higher hospitalization rates contributed to this concern. There-
fore the comparison of dropout rates is of some interest. Other
comparative data seem to reflect only small differences in
outcome. However, these differences would probably have
been greater had the study not allowed patients to transfer out
of their assigned treatment modality. Physicians, in fact, en-
couraged the transfer of patients who were not doing well.
Because of this, the nutritional assessments, for example,
probably underestimate the degree to which patients assigned
to IPD were losing body mass. The urea appearance rate of the
IPD patients was lower than that of the HD patients, an
observation which also suggests that nutritional status of the
IPD patients was relatively impaired. However, the lower rate
may also be explained by peritoneal losses of protein and amino
acids (unmeasured in this study) [311. Other studies comparing
selected patients assigned to HD and PD have found that PD
patients have significantly. but not dramatically, lower serum
albumin concentration [26, 32, 33]. Our data in randomized
patients confirm this observation but leave unaddressed its
relationship to nutritional status.
In contrast to many other [5. 7—9. 16—18. 32, 33]. but not all
studies [151, our PD patients did not have higher hematocrits
than the HD patients. Serum phosphorus has also been said to
be lower IS. 8], but we and others [7, 9] did not find this
difference. Perhaps the lack of difference in these areas is
simply due to our use of a random assignment process which
minimized the selection bias.
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Only two other studies [4, 51 have made a comprehensive
effort to compare clinical outcomes of matched HD and PD
patients. Although they did not use a randomizing protocol as
we did, the care in their design and the breadth of their outcome
measures invite special attention.
Roxe et al [4] used a prospective pairing procedure to obtain
groups comparable in age, sex, race, body size, blood pressure,
cause of renal disease, residual renal function, and a number of
other features. Their patients (N = 32) had been on main-
tenance dialysis for nearly 2 years preceding the study and
might therefore be regarded as si,ri'ivors and therefore not
representative of patients just starting dialysis therapy. In
contrast, we studied new patients. Their treatment schedule for
IPD was slightly shorter than ours, but the difference may be
insignificant. They monitored a larger number of biochemical
parameters than we did and found few differences. Unlike our
results, they found a small but significantly lower serum potas-
sium among IPD patients. They emphasized an apparent early
rise in hematocrit values in the IPD patients as compared to the
HD patients, but this difference was unsustained by the end of
6 months. Our analysis of hematocrit was not carried out in the
same fashion. Included in their comparison were quantitative
assessments of computerized electroencephalographic (EEG)
records and visual evoked and photic driving responses, which
were somewhat more abnormal among HD patients [341. As in
our study, they compared hospitalization and morbidity, but
found little or no difference except for the expected increase in
peritonitis in patients treated by IPD. Their lack of excessive
hospitalization for IPD patients, which contrasts with our
findings. may be an artifact from using dialysis-experienced
survivors of chronic illness. In support of this proposed expla-
nation, our data do not show excess hospitalization among the
IPD patients in the second 6th month period.
The second of these two comparison studies was done more
recently to compare home HD patients to home CAPD [51, but
made no attempt to randomize or prospectively pair the pa-
tients. The investigators did, however, retrospectively pair
subsets of patients whose demographic and medical back-
grounds were similar, a process which left them with relatively
small numbers of patients for comparison (N = 8). In this
study, Rubin et al found that the transfer of patients from one
mode of dialysis to another and the frequency of hospitalization
were greater in the CAPD patients, a finding which remained
true even in the comparison of the retrospectively matched
subsets. They noted that peritonitis was more common among
those of lower socio-economic status. Many biochemical differ-
ences were noted and yielded findings which were similar to
those of other less comprehensive comparisons [7—9, 32. 33].
Our own study presents problems in drawing conclusions as
well. The data are limited to an older form of peritoneal dialysis,
IPD, which has been said to be a less effective form of dialysis
than CAPD and therefore more likely to allow malnutrition to
occur [351. In addition, we relied, in part, on subjective and
semiquantitative assessments of patient well-being. Even
though these assessments lack rigid definitions and easily
validated measurements, they focus on features of patient
status that are often more meaningful to both the staff and
patients than are the more easily measured and calculated
laboratory assessments. We acknowledge more than the usual
uncertainty of these data. however. Finally, as the data collec-
tion turned out to be limited to men who had a slightly better
family and medical background. which might allow them to
undertake home dialysis more easily, the results may not apply
to the remaining patients screened for this study or to other
disadvantaged persons. Encouragingly, the patients who par-
ticipated in this randomized study had a poor educational
background and yet trained successfully for home dialysis.
Taken together, our study and the other two studies cited in
detail [4, 51 suggest (with due regard to the drawbacks of each
study) that hospitalization frequency may be excessive, for
peritoneal dialysis, especially early in the course of treatment.
Much of the excess hospitalization may be due in part to
peritonitis and may also be the cause of a higher dropout rate [5,
19]. Subtle malnutrition appears to be another problem with
IPD patients [351. While this problem is allegedly less likely to
occur in patients on CAPD [361, little solid evidence is avail-
able. The principal advantage of peritoneal dialysis, appearing
in all three studies is the shorter training time. Our study further
suggests that additional important advantages of IPD are the
lower incidence of cardiac morbidity (including arrhythmia,
pericarditis, and cardiac edema), the absence of vas-
cular access problems which can be fatal, and the lower
incidence of dialysis-related symptoms. We found no psycho-
logical advantage to IPD. Although others have contended that
CAPD offers an opportunity for better psychological rehabilita-
tion, this suggestion failed to be supported by the observations
of Evans, Manninen, Garrison. Hart, Blagg. Gutman, Hull, and
Lowrie (submitted for publication) in their cross-sectional eval-
uation of various modalities of therapies.
The planning and execution of this study itself invite some
discussion with regard to design of future studies. The study
results could be viewed as moot since it was carried out during
a state of flux in the technique of peritoneal dialysis and is being
published after the widespread use of IPD has ceased and been
replaced by CAPD. However, as it was a randomized study, we
can be secure that the outcome differences were strongly
related to the inherent differences in technique, especially the
cardiovascular difficulties on the one hand and the high drop-
out rates on the other. This last point remains germane in view
of the early reports of high drop-out rates for patients assigned
to CAPD [5, 191. Should a study of CAPD be designed along
similar lines? Our multicenter randomized study was conceived
and carried out in the same scientific spirit [21 which stimulates
this question. Perhaps the same outcome differences could have
been nearly as convincingly demonstrated by using a "compre-
hensive system of prognostic stratification" [3] wherein pa-
tients non-randomly assigned to each therapy are compared on
the basis of their inherent clinical strengths and weaknesses.
Such group comparisons are possible if we become able to
reliably measure clinical status, a process Feinstein calls
"clinimetrics" [371. This possibility must be considered in
planning further evaluation of "unstable therapy" because,
while random allocation study design is appealing, this and
other studies often border on being infeasible [37].
Appendix
This study was organized as follows under the auspices of the
VA Cooperative Studies Program: Study Chairman: F. K.
Curtis, Seattle, WA: Associate Chairman: Jack W. Coburn,
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Los Angeles; Coordinator: M. J. Blumenkrantz, Los Angeles
(Wadsworth), CA.
Participating Stations, Investigators, and StaffAssistants.
Charleston, SC: C. Thomas Tucker, Frances Ennis; Durham,
NC: Robert Gutman, Lucille Hardison; Hines, IL: C. Gandhi,
Janet Luby: Little Rock, AK: Galen Barbour, Gayle Pitts,
Debbie Pitts: Seattle, WA: Fu Shen, Kristin Vandehey: Chi-
cago, IL: Peter Ivanovich. Susan White (terminated April,
1977); Los Angeles (Wadsworth), CA: James Shinaberger.
Darlene Friday (terminated October, 1977): West Haven. CT:
John Goffinet, Helen Losnes (terminated October, 1977).
Executive Committee. F. K. Curtis, (Chairman) Seattle; Jack
W. Coburn, Los Angeles (Assoc. Chairman); M. J. Blumen-
krantz, Los Angeles (Coordinator); Yick-Kwong. Chan, West
Haven (Biostatistician); Galen Barbour, Little Rock: Robert
Gutman, Durham, NC; Ben Murawski, Boston (Consultant).
Biostatistics and Research Data Processing. West Haven
Cooperative Studies Program Coordinating Center (CSPCC).
Chief: Yick-Kwong Chan: Study Biostatistician: Yick-Kwong
Chan; Programmers: Irene Voynick, Dorothea Collins, Gary R.
Johnson: Statistical Assistants: Joyce Pritchett, Patricia Fer-
rucci, Roxane Posteraro (Former): Keypunch Operators: Stella
Marcinauskis, Velma Williams.
Special Laboratories. Manfred Morris (Lipid Laboratory),
Little Rock.
Operations Committee. George A. Porter (Chairman), Port-
land; Cohn White, New Haven: Christopher Blagg. Seattle:
Frank A. Gotch, San Francisco. Human Rights Committee.
Margaret Flower (Chairman), West Haven: Jack H. Evans,
New Haven; Margaret A. Farley. New Haven (to 6/81):
Barbara A. Kathe, West Hartford (7/8 1—): Willis Pritchett, New
Haven.
Cooperative Studies Program Central Administration. James
A. Hagans. Chief: Ping C. Huang. Staff Assistant.
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